Christina M. Lill, MD, MS

Group leader



(1) Research group leader, Genetic and Molecular Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Germany (since 2018)

(2) Lecturer (part-time), School of Public Health, Imperial College London (ICL), UK (since 2018)

(3) Resident in Medical Genetics, Institute of Human Genetics, University of Lübeck, Germany (since 2016)


Resident in Medical Genetics, Charité University Medicine, Berlin, Germany (2008-2009), postdoctoral researcher, Johannes Gutenberg University, Mainz, Germany (2010-2011), postdoctoral researcher, Max Planck Institute for Molecular Genetics, Berlin, Germany (2012-2014), postdoctoral researcher, Institute of Neurogenetics, University of Lübeck, Germany (2015-2016), Research group leader, Institute of Neurogenetics, University of Lübeck, Germany (2016-2018)



Institution and location Degree Year Field of study
Ludwig Maximilian University Munich M.D. 2005 Medicine
Massachusetts Institute for Neurodegenerative Disease, Harvard Medical School, Boston Predoctoral fellowship 2006-07 Neuroscience, genetics
Charité University Medicine, Berlin Residency 2008-09 Medical genetics (training in neurology)
Westfälische Wilhelms University, Münster Dissertation (Dr. med.) 2011 Neurogenetics
Johannes Gutenberg University, Mainz M.Sc. 2015 Epidemiology
University of Lübeck, Lübeck, Germany Residency 2016-current Medical genetics (genetic counseling)


Major current funding (projects as (co-)PI only):

DFG (FOR2488/1, GZ LI 2654/2-1), budget: €277,760, funding period: 2016-2020 (PI)

ERC/H2020 (#732592), budget: €1,112,545, funding period: 2017-2022 (local co-PI)

MJFF, budget: ~€650,000, funding period: starting in autumn 2019-2022 (PI)


Selected publications (from >80 papers; >3,600 citations; h-index: 26, source: Scopus database, June 2019):

(1) Lill CM, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: The PDGene database. PLoS Genet, 2012; 8(3): e1002548; IF = 8.5

(2) Lill CM, et al. MANBA, CXCR5, SOX8, RPS6KB1, and ZBTB46 are genetic risk loci for multiple sclerosis. Brain, 2013;136(Pt 6):1778-82; IF = 10.2

(3) Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet, 2014 46(9):989-93; IF = 29.4

(4) Lill CM, et al. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimers Dement, 2015;11(12):1407-1416;IF = 11.6

(5) Wohlers I, Bertram L, Lill CM. Evidence for a potential role of miR-1908-5p and miR-3614-5p in autoimmune disease risk using integrative bioinformatics. J Autoimmun. 2018;94:83-89. .; IF = 7.5

(6) Paul KC*, Schulz J*, Bronstein JM, Lill CM*, Ritz BR*. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease. JAMA Neurol. 2018;75(3):360-366; IF = 12.3

(7) Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rücker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM. Meta-analyses identify differentially expressed microRNAs in Parkinson’s disease, Ann Neurol, 2019;85(6):835-851.; IF = 10.2

*shared first or last authors


Awards & memberships


2016     “Young Leaders in Science” Program of the Schering Foundation
2015     Renate-Maaß Award for Brain Research
2015     Travel award of the GlaxoSmithKline foundation
2009     Travel award of the Felgenhauer foundation
2006 – 2007     MD thesis research scholarship (Promotionsstipendium) of the German Academic Exchange Service (Deutscher Akademischer Austauschdienst)
2000 – 2005     Scholarship of the GmbH & Co KG
1999 – 2005     Scholarship of the German National Merit Foundation (Studienstiftung des deutschen Volkes)

Current memberships

Co-leader of the Epidemiology Working Group of the International Parkinson and Movement Disorder Society (MDS)
Co-leader of the Epidemiology and Statistics Core at the Genetic Epidemiology of Parkinson’s Disease Consortium (GEO-PD)
Editorial boards of Gene, Mol Cell Probes (Elsevier)
Extended Steering Committee of the Berlin Aging Study II (BASE II)
Genetic Epidemiology of Parkinson’s Disease Consortium (GEO-PD)
Harvard European Alumni Training NETwork for the study of neurodegenerative disorders (HEAT-NET)
International Multiple Sclerosis Genetics Consortium (IMSGC)